SVA 0.00% 2.2¢ simavita limited

News: SVA Simavita Ltd says co signed 3 year distribution agreement with Onemed A/S, page-2

  1. 381 Posts.
    lightbulb Created with Sketch. 4
    SIMAVITA MARKET UPDATE PIVOT – Our Strategy and Commitment For Immediate Release: August 9, 2017 Sydney Australia - Simavita Limited (ASX:SVA) a world leader in smart, wearable and disposable sensors for the global diaper industry, today provided a progress report on its recently announced corporate strategy – PIVOT – the Company’s focus upon major and rapidly growing markets for adult and infant diapers which currently amount to over US$21bn annually. The Simavita product range encompasses the Company’s incontinence assessment sensors and tools including ASSESSPLUS™ and SIM™. Our new core platform technology is focused upon delivering ALERTPLUS™, a hyper low cost product for all adult and infant diapers. ALERTPLUS™ hyper low cost sensor platform technology for all diapers: Simavita has now completed a number of important milestones: 1. Patents for our core platform technology have been granted in all major markets. 2. ALERTPLUS™ has been manufactured in low volume through a manufacturing partner 3. A fully downloadable APP for smart devices is available and a low cost data capture device has been developed using industry standard electronic components. 4. A marketing assessment has been completed and strategy for roll out determined. 5. Detailed discussions have commenced with a number of major international manufacturers. ASSESSPLUS™ and SIM™ - Simavita’s Incontinence Assessment Products: ASSESSPLUS™ revenues are growing across all markets. Furthermore, many existing SIM™ users have converted to ASSESSPLUS™. EUROPEAN MARKET We are delighted to announce that Simavita has signed a 3 year distribution agreement with OneMed A/S covering The Netherlands and Nordic Countries. OneMed is a large distributor of medical product in Europe with an annual turnover of approximately €400m and provide medical supplies and services to over 33,000 healthcare providers. Simavita Chairman Michael Spooner said “We’re very pleased to have OneMed representing Simavita in Europe. OneMed goals are very aligned to ours, with a focus on patient outcomes and total cost of care. Simavita’s incontinence solutions are complementary to the products and services that OneMed offer in the incontinence and wound care market.” OneMed will replace Abena as Simavita’s representative in Denmark. Simavita has also made substantial headway in identifying distribution partners in both the UK and
 
watchlist Created with Sketch. Add SVA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.